Parkinson’s disease is a progressive brain disorder that affects movement, balance, and many aspects of daily life. It occurs when nerve cells in a part of the brain that produces dopamine slowly become damaged or die.
Dopamine is a chemical that helps control movement and coordination. When dopamine levels drop, people may develop symptoms such as tremors, stiffness, slow movement, and problems with balance.
Although Parkinson’s disease is commonly associated with shaking or tremors, the condition is much more complex. Many people also experience fatigue, difficulty walking, posture problems, sleep disturbances, and emotional challenges such as anxiety or depression.
Because the disease develops slowly, symptoms often change over time, making it important for researchers to understand how patients experience the condition as it progresses.
A new study published in the Journal of Neurology provides valuable insights into how symptoms and daily challenges evolve for people living with early-stage Parkinson’s disease. The research was led by Dr. Jamie Adams and Dr. Jennifer Mammen, long-time collaborators with the Critical Path Institute’s Critical Path for Parkinson’s consortium.
Their study, titled “Three years later: tracking bothersome symptoms and impacts for people with early Parkinson’s disease,” followed individuals over a three-year period to observe how their symptoms and daily functioning changed.
The researchers focused on people who were in the early stages of Parkinson’s disease. Studying this group is important because early changes in the disease may reveal clues that help doctors monitor progression and design better treatments.
The team collected information from participants over time and used modern digital technology to track how the disease affected them in their everyday lives.
One key feature of the study was the use of wearable devices. These small electronic devices can be worn on the body and are able to measure movement and activity throughout the day.
By using these tools, researchers were able to observe how people walked, balanced, and moved in real-world situations instead of only relying on occasional clinic visits. This approach provides a more realistic picture of how Parkinson’s affects daily life.
Over the three-year study period, the researchers found that many aspects of physical functioning gradually worsened. Even when some individual symptoms appeared to level off or change slowly, overall daily functioning continued to decline.
This means that people with early Parkinson’s disease may experience increasing difficulty completing everyday activities even if certain symptoms seem stable.
Among all the symptoms studied, problems with walking, balance, and posture were reported as the most bothersome. Many participants said that maintaining stability while walking or standing became increasingly difficult. These challenges can raise the risk of falls, which is a major concern for people living with Parkinson’s disease.
Participants also reported that everyday tasks required more effort as time passed. Activities that once felt simple, such as walking across a room, climbing stairs, or carrying objects, gradually became more tiring.
This growing physical effort also had emotional and social effects. Some participants described feeling more stress, frustration, or concern about losing independence.
The researchers emphasized that understanding these real-life experiences is extremely important when designing clinical trials for new treatments. Traditional medical assessments often focus on specific symptoms measured during doctor visits. However, these assessments may not fully capture the everyday challenges that patients face.
Dr. Diane Stephenson, Vice President of Neurology at the Critical Path Institute and Executive Director of the Critical Path for Parkinson’s consortium, explained that patient-centered measurement tools can help drug developers design better clinical trials.
By understanding how Parkinson’s affects people in their daily routines, researchers can focus on treatments that improve the outcomes that matter most to patients.
Another important aspect of the study was the integration of patient perspectives. Participants shared their experiences through interviews and surveys. Combining these personal reports with digital measurements from wearable devices allowed researchers to connect physical changes with how patients actually felt and functioned in their daily lives.
Experts involved in the research believe that digital health technology may play a growing role in Parkinson’s research. Wearable devices can provide continuous data about movement, balance, and activity levels. When combined with patient feedback, these tools may help doctors detect subtle changes in the disease much earlier than traditional methods.
The findings also highlight the importance of listening to people who live with Parkinson’s disease. Sarah Zenner Dolan, a participant in the study who lives with early-onset Parkinson’s, explained that the research reflects the real experiences of patients and shows how wearable technology can help track symptoms in real time.
Researchers from The Michael J. Fox Foundation for Parkinson’s Research also contributed to the project. Clinical Research Lead Yuge Xiao noted that combining digital data with patient interviews helps ensure that the measurements collected truly reflect meaningful changes in patients’ lives.
Reviewing the findings of this study shows that Parkinson’s disease progression is not always captured by simple symptom checklists.
While some symptoms may appear stable, the overall burden of the disease can still increase as everyday tasks become more difficult. The research also demonstrates that wearable technology and patient-reported experiences can provide a more complete understanding of disease progression.
However, the study also has limitations. Because Parkinson’s disease can vary widely between individuals, longer and larger studies will be needed to confirm these patterns. Future research may explore how digital monitoring tools can help doctors detect changes earlier and test new treatments more effectively.
Overall, the study represents an important step toward more patient-centered research in Parkinson’s disease. By tracking symptoms, physical movement, and personal experiences over time, scientists are gaining a clearer understanding of how the disease affects daily life.
This knowledge may help guide the development of better treatments and improve the design of future clinical trials.
If you care about Parkinson’s disease, please read studies that Vitamin B may slow down cognitive decline, and Mediterranean diet could help lower risk of Parkinson’s.
For more health information, please see recent studies about how wheat gluten might be influencing our brain health, and Olive oil: a daily dose for better brain health..
The research findings can be found in the Journal of Neurology.
Copyright © 2026 Knowridge Science Report. All rights reserved.
